Curis Inc CRIS

US Biotechnology

$5.02 ▲ +1.21% (+$0.06)

🎢 High Beta 📅 Earnings This Week

Open $5.00

Prev Close $4.96

Day Range $4.92 – $5.17

52W Range $3.61 – $39.00

Market Cap $9.78M

Beta 3.42

EPS (TTM) $-1.20

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2000-08-01
Shares Out.	1,950,000
Website	curis.com/ ↗
Phone	13026587581
Employees	24
Net Income	-$24.2M
Total Assets	$29.7M
Total Liabilities	$17.0M
Equity	$12.7M

About Curis Inc

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Curis Inc is a publicly traded company under the ticker symbol CRIS on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.